Yang, Felix
Bousnina, Imein
Madej, Anne
Kalamegham, Rasika
Article History
Received: 1 November 2024
Accepted: 22 April 2025
First Online: 4 May 2025
Declarations
:
: This research was conducted as part of Felix Yang’s Howard University Pharmaceutical Industry Fellowship Program in partnership with Genentech Inc, A Member of the Roche Group. Imein Bousnina, Anne Madej, and Rasika Kalamegham are full time employees of Genentech, A Member of the Roche Group. None of the authors have any financial interest other than employment by Genentech.